Jacquinet Adeline, Bonnard Adeline, Capri Yline, Martin Didier, Sadzot Bernard, Bianchi Elettra, Servais Laurent, Sacré Jean-Paul, Cavé Hélène, Verloes Alain
Department of Genetics, Sart Tilman University Hospital, Belgium.
Department of Genetics, APHP-Robert DEBRE University Hospital, Denis Diderot School of Medicine, Paris University, France.
Eur J Med Genet. 2020 Jan;63(1):103617. doi: 10.1016/j.ejmg.2019.01.007. Epub 2019 Jan 19.
Mutations in LZTR1, already known to be causal in familial schwannomatosis type 2, have been recently involved in a small proportion of patients with autosomal dominant and autosomal recessive Noonan syndrome. LZTR1 is also a driver gene in non syndromal glioblastoma. We report a 26-year-old patient with typical Noonan syndrome, and the dominantly transmitted c.850C > T (p.(Arg284Cys)) variant in LZTR1. An oligoastrocytoma was diagnosed in the patient at the age of 22 years; recurrence of the tumor occurred at age 26, as a ganglioblastoma. The patient had been transiently treated with growth hormone between ages 15 and 17. Considering the implication of LZTR1 in sporadic tumors of the nervous system, we hypothesize that gliomas are a possible complication of LZTR1-related Noonan syndrome. This report also supports a possible link between occurrence of a cerebral tumor in Noonan syndrome and a previous treatment with growth hormone.
LZTR1突变已被证实是2型家族性神经鞘瘤病的病因,最近在一小部分常染色体显性和常染色体隐性努南综合征患者中也发现与之有关。LZTR1也是非综合征性胶质母细胞瘤中的驱动基因。我们报告了一名26岁患有典型努南综合征的患者,其LZTR1基因存在显性遗传的c.850C>T(p.(Arg284Cys))变异。该患者22岁时被诊断出少突星形细胞瘤;26岁时肿瘤复发,为成神经节细胞瘤。患者在15至17岁期间曾接受过生长激素短期治疗。考虑到LZTR1在散发性神经系统肿瘤中的作用,我们推测胶质瘤可能是LZTR1相关努南综合征的一种并发症。本报告还支持努南综合征患者发生脑肿瘤与先前生长激素治疗之间可能存在联系。